Status:
COMPLETED
Registry of Coronavirus Complications - CORRELATION WITH GLYCOMIC PROFILE in COVID-19 Patients
Lead Sponsor:
Papa Giovanni XXIII Hospital
Collaborating Sponsors:
GENOS
Conditions:
Chronic Pain
Morbidity, Multiple
Eligibility:
All Genders
18+ years
Brief Summary
COVID infection has resulted in multi-organ injury and may result in cardiovascular, pulmonary, neurological, and muscular damage. It is associated with significant asthenia and the long-term effects ...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of COVID19 virus infection (buffer/BAL/positive IgG serology)
- Age \>18 years
- Able to express informed consent to participate in the study
Exclusion
- patients unable to express consent,
- patients aged \<18 yr,
- with signs and symptoms compatible with Covid-19 but without certified diagnosis by swab/BAL or serological examination of presence of COVID IgG antibodies
Key Trial Info
Start Date :
March 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 10 2022
Estimated Enrollment :
374 Patients enrolled
Trial Details
Trial ID
NCT04788433
Start Date
March 4 2021
End Date
September 10 2022
Last Update
April 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aast Papa Giovanni Xxiii
Bergamo, Italy, 24127